Sign In
Buy LLY
$1,231.58
+45.87 (+3.87%)
At Close: Aug 10, 2026
GDP Declined in First Quarter
12:47pm, Thursday, 28'th Apr 2022
GDP Declined in First Quarter
Eli Lilly (LLY) Beats on Q1 Earnings, Ups Sales View, Stock Rises
12:47pm, Thursday, 28'th Apr 2022
Eli Lilly (LLY) beats first-quarter estimates for both earnings and sales and ups its sales outlook for 2022. The stock rises in pre-market trading.
Q1 GDP Negative; Q1 Earnings Beats from CAT, LLY, MCD
12:04pm, Thursday, 28'th Apr 2022
GDP reported the first negative quarter since Q2 2020, which was considered the "heart" of the pandemic.
Eli Lilly Q1 results: ‘Russia isn't a big part of our portfolio'
11:33am, Thursday, 28'th Apr 2022
Shares of Eli Lilly & Co (NYSE: LLY) opened 3.5% up on Thursday after the pharmaceutical company reported market-beating results for its fiscal first quarter on strong COVID-19 antibodies sales. Eli L
Eli Lilly (LLY) Q1 Earnings and Revenues Top Estimates
09:02am, Thursday, 28'th Apr 2022
Lilly (LLY) delivered earnings and revenue surprises of 12.93% and 3.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Eli Lilly drug tirzepatide meets weight-loss goals in obesity trial
07:08am, Thursday, 28'th Apr 2022
A highly anticipated clinical trial from Eli Lilly showed its Type 2 diabetes drug met its primary endpoints. CNBC's Meg Tirrell joins 'Squawk Box' to break down the results.
Eli Lilly stock rallies after earnings beat expectations, as COVID-19 antibodies revenue jumps 81%
06:45am, Thursday, 28'th Apr 2022
Shares of Eli Lilly & Co. LLY, +0.80% rallied 1.8% in premarket trading Thursday after the drug maker reported first-quarter profit and revenue that beat expectations, as better-than-forecast COVID-19
Drugmaker Eli Lilly reports near 40% jump in quarterly profit
06:36am, Thursday, 28'th Apr 2022
Drugmaker Eli Lilly and Co reported a near 40% rise in quarterly profit on Thursday, helped by strong demand for its top-selling diabetes drug and newer cancer treatments.
Eli Lilly Beats Estimates and the Stock Rises on Revenue Guidance Boost
06:34am, Thursday, 28'th Apr 2022
Eli Lilly raises its sales forecast for 2022 to $28.8 billion to $29.3 billion.
Drug/Biotech Stocks Q1 Earnings Due on Apr 28: MRK, LLY & More
03:18pm, Wednesday, 27'th Apr 2022
Let us look at the five biotech/pharma companies, slated to release quarterly results on Apr 28.
Does Eli Lilly's Future Depend on its Alzheimer's Drug?
08:11am, Saturday, 23'rd Apr 2022
Medicare's decision raises uncertainty about a key upcoming treatment.
3 Dividend Stocks You Can Buy and Hold for Decades
06:08am, Saturday, 23'rd Apr 2022
Each of these companies has a long history of success.
J&J Sets in Motion Drug/Biotech Q1 Earnings: 3 Stocks to Buy
11:19am, Thursday, 21'st Apr 2022
Investors typically look at J&J's (JNJ) results to gauge how the rest of the drug sector will fare.
Lilly Confirms Date and Conference Call for First-Quarter 2022 Financial Results Announcement
10:00am, Tuesday, 19'th Apr 2022
INDIANAPOLIS , April 19, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its first-quarter 2022 financial results on Thursday, April 28, 2022. Lilly will also conduct a conference
Is There A Better Pick Over Eli Lilly Stock?
06:00am, Tuesday, 19'th Apr 2022
We think that Netflix stock currently is a better pick compared to Eli Lilly stock, given its better prospects and a comparatively lower valuation. LLY stock trades at about 10.2x trailing revenues, c
